PLAU and breast cancer: BC-ES cells have an elevated output of signals such as EGF, IGF, IGFBP, BMP, EDN, PLAU, and FLT3, as well as an increased reception of VISFATIN (from IFI27+), PERIOSTIN (from BC-AS2), and COMPLEMENT (from IFI27+).